Neurology Publications


Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease;
Sauerbier, A, Herberg, J, Stopic, V, Loehrer, PA, Ashkan, K, Rizos, A, Jost, ST, Petry-Schmelzer, JN, Gronostay, A, Schneider, C, Visser-Vandewalle, V, Evans, J, Nimsky, C, Fink, GR, Antonini, A, Martinez-Martin, P, Silverdale, M, Weintraub, D, Schrag, A, Ray Chaudhuri, K, Timmermann, L, Dafsari, HS, Adler, C, Bhidayasiri, R, Borghammer, P, Barone, P, Brooks, DJ, Brown, R, Cantillon, M, Carroll, C, Coelho, M, Falup-Pecurariu, C, Henriksen, T, Hu, M, Jenner, P, Jeon, B, Kramberger, M, Kumar, P, Kurtis, M, Leta, V, Lewis, S, Litvan, I, Lyons, K, Martino, D, Masellis, M, Mochizuki, H, Morley, JF, Nirenberg, M, Odin, P, Pagonabarraga, J, Panicker, J, Pavese, N, Pekkonen, E, Postuma, R, Rodriguez Violante, M, Rosales, R, Schapira, A, Simuni, T, Stocchi, F, Storch, A, Subramanian, I, Tagliati, M, Tinazzi, M, Toledo, J, Tsuboi, Y & Walker, R 2024, , npj Parkinsons Disease, vol. 10, no. 1, 114. https://doi.org/10.1038/s41531-024-00701-6

Rethinking clinical trials in restless legs syndrome: A roadmap;
Garcia-Borreguero, D, Black, J, Earley, CJ, Fulda, S, Högl, B, Manconi, M, Ondo, W, Roth, T, Trenkwalder, C & Winkelman, JW 2024, , Sleep Medicine Reviews, vol. 77, 101978. https://doi.org/10.1016/j.smrv.2024.101978

Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease;
Appleton, J, Finn, Q, Zanotti-Fregonara, P, Yu, M, Faridar, A, Nakawah, MO, Zarate, C, Carrillo, M, Dickerson, BC, Rabinovici, G, Apostolova, LG, Masdeu, JC & Pascual, B 2024, , Brain. https://doi.org/10.1093/brain/awae234

SARA captures disparate progression and responsiveness in spinocerebellar ataxias;
Petit, E, Schmitz-Hübsch, T, Coarelli, G, Jacobi, H, Heinzmann, A, Figueroa, KP, Perlman, SL, Gomez, CM, Wilmot, GR, Schmahmann, JD, Ying, SH, Zesiewicz, TA, Paulson, HL, Shakkottai, VG, Bushara, KO, Kuo, SH, Geschwind, MD, Xia, G, Pulst, SM, Subramony, SH, Ewenczyk, C, Brice, A, Durr, A, Klockgether, T, Ashizawa, T & Tezenas du Montcel, S 2024, , Journal of Neurology, vol. 271, no. 7, pp. 3743-3753. https://doi.org/10.1007/s00415-024-12475-1

Compound Muscle Action Potential and Myosin-Loss Pathology in Patients with Critical Illness Myopathy: Correlation and Prognostication;
Shelly, S, Soontrapa, P, Madigan, NN, Polzin, MJ, Singh, TD, Sista, SRS, Paul, P, Braksick, SA, Liao, B, Windebank, AJ, Boon, AJ, Litchy, WJ, Milone, M & Liewluck, T 2024, , Neurology, vol. 103, no. 1, e209496. https://doi.org/10.1212/WNL.0000000000209496

Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis;
Nelson, PT, Fardo, DW, Wu, X, Aung, KZ, Cykowski, MD & Katsumata, Y 2024, , Journal of Neuropathology and Experimental Neurology, vol. 83, no. 6, pp. 396-415. https://doi.org/10.1093/jnen/nlae032

Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians;
Wyman-Chick, KA, Chaudhury, P, Bayram, E, Abdelnour, C, Matar, E, Chiu, SY, Ferreira, D, Hamilton, CA, Donaghy, PC, Rodriguez-Porcel, F, Toledo, JB, Habich, A, Barrett, MJ, Patel, B, Jaramillo-Jimenez, A, Scott, GD & Kane, JPM 2024, , Neurology and Therapy, vol. 13, no. 3, pp. 885-906. https://doi.org/10.1007/s40120-024-00620-x

A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis;
Thonhoff, JR, Beers, D, Zhao, W, Faridar, A, Thome, AD, Wen, S, Zhang, A, Wang, J & Appel, SH 2024, , Frontiers in Neurology, vol. 15, pp. 1415106. https://doi.org/10.3389/fneur.2024.1415106